Manipal Hospitals Initiates IPO Roadshows Aims to Overcome Market Sentiment Meta to Test AI Subscription Services Starting at 799 Per Month Baron Capital and Ticker BCTK A Profile of the Investment Firm Behind the Symbol International Students Face Mounting Barriers to US Employment as Hiring Market Weakens OpenAIs ChatGPT Now Links to Financial AccountsPrivacy Experts Caution Users EU and Mexico Sign Updated Trade Deal to Reduce Dependence on US and China DRDGOLD Q3 2014 Earnings NarrowerThanExpected Loss Amidst Challenging Gold Market Savara Inc SVRA Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline SOFI Q1 2026 Earnings EPS Slightly Below Estimates Stock Dips Marginally MFG Q1 2026 Earnings Strong EPS Beat of 284 as Net Interest Income Rises Yet Stock Edges Lower Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported Ferguson Enterprises FERG Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher Royal Caribbean RCL Faces Resistance as Shares Pull Back from Recent Highs PrimeEnergy Resources PNRG Declines 37 as Shares Test Key Support Levels Terra Income Fund Notes TFSA Surge 554 as FixedIncome Market Rebounds Nuveen Real Asset Income and Growth Fund JRI Edges Higher Tests Key Resistance Zone OFS Credit Company OCCI Dips 21 Toward Key Support as Technical Signals Deteriorate OpenAI Gains Early Lead in AI IPO Race Amid Confidential Filing Reports FBIN Q1 2026 Earnings Narrow EPS Miss on Flat Revenue as Stock Advances Kenon Holdings KEN Retreats 285 Support Levels in Focus After Pullback ARTL Q4 2025 Earnings EPS Surprises Positively but Shares Decline on No Revenue SSR Mining Q1 2026 Earnings EPS Surges Past Estimates by 318 as Stock Declines CRVS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline GHC Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency Limoneira LMNR Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Stock Eases SLB Q1 2026 Earnings EPS Slightly Misses Estimates Amid Stable Operations Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges